Recurrence and metastasis of endometrial cancer

What should I do if endometrial cancer recurs and metastasizes? When endometrial cancer develops to the late stage, incomplete treatment and unreasonable treatment methods may lead to recurrence and metastasis. So, what should I do if endometrial cancer recurs and metastasizes? Let's take a look at what the experts say:

What should I do if endometrial cancer recurs and metastasizes? Late-stage recurrence and metastasis of endometrial cancer include systemic metastasis to the liver, lungs, bones, lymph nodes, blood vessels, and recurrence in the pelvic wall and paracervix. Some people have counted the recurrence sites after radiotherapy.

The clinical symptoms of late-stage recurrence and metastasis of endometrial cancer will also vary depending on the site of recurrence and metastasis. Recurrence in the uterus or vagina often causes irregular vaginal bleeding or foul-smelling leucorrhea; recurrence in the pelvic wall or paracervix may cause pain and edema in the affected lower limb, pain in the lumbosacral region or lower abdomen, and a paracervical mass or a fixed mass in the sacral fossa may be palpated during pelvic examination; metastasis to the rectum or bladder often causes blood in the stool or urine; bone metastasis often causes local pain; lung metastasis may cause coughing and chest pain.

If the above symptoms and signs appear after treatment of endometrial cancer, the possibility of recurrence should be considered. Local recurrence of the cervix and vagina can be diagnosed easily by vaginal smear cytology and biopsy. Attention should be paid to the differentiation of pelvic masses from lymphocele after radical surgery, pelvic wall inflammation, and paracervical connective tissue fibrosis after radiotherapy. Local fine needle puncture for cell smear and pathological examination can help to clarify the diagnosis. B-ultrasound, pyelography, isotope renal imaging and CT pelvic examination have certain reference value for diagnosing recurrent cancer.

What should I do if endometrial cancer recurs and metastasizes?

The treatment of patients with advanced recurrence and metastasis of endometrial cancer should be based on radiotherapy and chemotherapy combined with autoimmune therapy. Autoimmune therapy is a tumor treatment technology that is superior to surgery, radiotherapy and chemotherapy, and is praised by many scientists and medical scholars as "a treatment technology that may conquer cancer in the 21st century."

Autologous immune therapy technology collects 60 ml of peripheral blood from the patient, separates the patient's own anti-cancer immune cells through a blood separator, and cultured in a high-standard laboratory. When the number reaches 10 to the power of 10 and the activity is above 95%, the cells are returned to the body. This is a treatment method that uses the patient's own immune anti-cancer cells to directly kill cancer cells. This also shows that the technology is safe and effective.

Different from traditional treatment methods:

1. Autologous immune therapy technology mainly mobilizes the body's natural anti-cancer ability and restores the balance of the body's internal environment. Clinically, it is often combined with biological immunotherapy after surgery or radiotherapy and chemotherapy.

2. Biological immunotherapy can kill residual cancer cells after surgery, improve the effect of radiotherapy and chemotherapy, enhance the patient's immune ability, and better prevent metastasis and recurrence. It can reduce the toxicity and increase the efficacy of radiotherapy and chemotherapy, which is conducive to the smooth progress of radiotherapy and chemotherapy.

[Warm Tips] The above is an introduction to what to do if endometrial cancer recurs or metastasizes. I hope it will be helpful to everyone. If endometrial cancer patients experience recurrence or metastasis, they should go to a regular hospital in time and choose a reasonable and effective treatment method based on their condition to avoid the spread of the disease and cause serious consequences.